Patient Reported Outcomes and Patient Voice Among Patients Diagnosed With Low Risk Myelodysplastic Syndrome (LR-MDS) or Unexplained Anemia In Japan

Clinical trial NCT07008820 · COMPLETED

Trial details

NCT number: NCT07008820
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Study type: OBSERVATIONAL

Myelodysplastic Syndrome (MDS)

Start date: 2025-05-13
Primary completion: 2026-02-24
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.